CNS Therapeutics Market Worth $128.9 Billion By 2025 | CAGR: 5.9%

Transdermal methods to deliver CNS medicines in rapidly growing sectors of the Life Sciences industry not only help patients meet their daily dosage requirements—they’re offering investors opportunities to capitalize on swifter delivery of gains and earlier profits.    Our research and due diligence indicates the following company: Aequus Pharmaceuticals Inc. (OTC: AQSZF / CSE: AQS), […]

error: Content is protected !!